rs750409379
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 3P and 2B. PM1PP2BP4BP6
The NM_000218.3(KCNQ1):c.1726G>A(p.Val576Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,613,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V576V) has been classified as Likely benign.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 1Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Jervell and Lange-Nielsen syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
- atrial fibrillation, familial, 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- short QT syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
- short QT syndrome type 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNQ1 | NM_000218.3 | c.1726G>A | p.Val576Ile | missense_variant | Exon 14 of 16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KCNQ1 | ENST00000155840.12 | c.1726G>A | p.Val576Ile | missense_variant | Exon 14 of 16 | 1 | NM_000218.3 | ENSP00000155840.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152134Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000637 AC: 16AN: 250990 AF XY: 0.0000810 show subpopulations
GnomAD4 exome AF: 0.0000746 AC: 109AN: 1461812Hom.: 0 Cov.: 32 AF XY: 0.0000866 AC XY: 63AN XY: 727204 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152134Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74314 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Variant summary: KCNQ1 c.1726G>A (p.Val576Ile) results in a conservative amino acid change located in the KCNQ voltage-gated potassium channel domain (IPR013821) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 250990 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in KCNQ1 causing Jervell And Lange-Nielsen Syndrome (6.4e-05 vs 0.0024), allowing no conclusion about variant significance. c.1726G>A has been reported in the literature in individuals affected with Long QT Syndrome (Berge_2008, Mullally_2013, Giudicessi_2013). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 18752142, 32048431, 23392653, 23174487). ClinVar contains an entry for this variant (Variation ID: 200813). Based on the evidence outlined above, the variant was classified as uncertain significance. -
p.Val576Ile in exon 14 of KCNQ1: This variant is not expected to have clinical s ignificance due to a lack of conservation across species, including mammals. Of note, 13 mammals have an Ile at this position despite high nearby amino acid con servation. In addition, computational prediction tools do not suggest a high lik elihood of impact to the protein. It has also been identified in 5/65838 Europea n chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstit ute.org). Although this variant has been reported in 2 individuals with LQTS (1 with intact hearing who carried a second likely pathogenic variant) (Mullally 20 13, Giudicessi 2013), based on the lack of conservation at this position, this v ariant is likely benign. -
Atrial fibrillation, familial, 3;C1865019:Short QT syndrome type 2;C4551509:Jervell and Lange-Nielsen syndrome 1;C4551647:Long QT syndrome 1 Uncertain:1
The c.1726G>A p.(Val576Ile) variant in KCNQ1 has previously been reported heterozygous in an individual with long QT syndrome [PMID: 23174487] and compound heterozygous in an individual with Jervell and Lange-Nielsen syndrome without deafness [PMID: 23392653]. This variant has been deposited in ClinVar [ClinVar ID:200813] as Variant of Uncertain Significance, Likely benign, and Benign. The 1726G>A variant is observed in 24 alleles (~0.003% MAF with 0 homozygotes) in population databases (gnomAD v2.1.1 and v3.1.2, TOPMed Freeze 8), suggesting it is not a common benign variant in the populations represented in those databases.The c.1726G>A variant is located in exon 14 of this 16-exon gene and predicted to replace a poorly conserved valine amino acid with isoleucine at position 576. In silico predictions are inconclusive of the variant's effect (CADD v1.6 = 17.03, REVEL = 0.622); however, there are no functional studies to support or refute these predictions. Based on available evidence this c.1726G>A p.(Val576Ile) variant identified in KCNQ1 is classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23392653, 23174487, 32048431) -
Long QT syndrome Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 576 of the KCNQ1 protein (p.Val576Ile). This variant is present in population databases (rs750409379, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of KCNQ1-related conditions (PMID: 18752142, 23174487, 23392653). ClinVar contains an entry for this variant (Variation ID: 200813). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.V576I variant (also known as c.1726G>A), located in coding exon 14 of the KCNQ1 gene, results from a G to A substitution at nucleotide position 1726. The valine at codon 576 is replaced by isoleucine, an amino acid with highly similar properties, and is located in the C-terminal, cytoplasmic region of the protein. This variant co-occurred with a second KCNQ1 variant in an individual with long QT syndrome and intact hearing whose mother, with a normal QTc interval, carried only the p.V576I variant; however, the father was unavailable for testing (Giudicessi JR et al. Circ Cardiovasc Genet, 2013 Apr;6:193-200). This variant has also been detected in long QT syndrome cohorts; however, details were limited (Mullally J et al. Heart Rhythm, 2013 Mar;10:378-82; Berge KE et al. Scand. J. Clin. Lab. Invest. 2008 ;68(5):362-8). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Cardiac arrhythmia Uncertain:1
This missense variant replaces valine with isoleucine at codon 576 of the KCNQ1 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in several individuals with long QT syndrome (PMID: 18752142, 23174487, 23392653). This variant co-occurred with a second KCNQ1 variant in an individual with long QT syndrome and intact hearing whose mother, with a normal QTc interval, carried only this variant (PMID: 23392653). This variant has been identified in 16/250990 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Long QT syndrome 1 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at